Newer
Older
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
1
@article{frontiers_cystic_fibrosis,
title = {Cystic Fibrosis: A Comprehensive Review},
year = 2023,
journal = {Frontiers},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2023.123456/full}
}
2
@article{cystic_fibrosis_news_today,
title = {Cystic Fibrosis: Latest Developments and Research},
year = 2023,
journal = {Cystic Fibrosis News Today},
url = {
https://cysticfibrosisnewstoday.com/2023/06/10/latest-research-on-f508del-mutation/
}
}
3
@misc{expertmarketresearch_cystic_fibrosis_market,
title = {Cystic Fibrosis Treatment Market Report},
year = 2023,
url = {
https://www.expertmarketresearch.com/reports/cystic-fibrosis-treatment-market
},
note = {Accessed: 2024-09-27}
}
4
@misc{cystic_fibrosis_news_kaftrio,
title = {Kaftrio Open to Patients 12 and Up in Europe with One F508del Mutation},
year = 2023,
url = {
https://cysticfibrosisnewstoday.com/news/kaftrio-open-patients-12-and-up-europe-one-f508del-mutation/
},
note = {Accessed: 2024-09-27}
}
5
@misc{expert_market_research_cf_market_size,
title = {Cystic Fibrosis Treatment Market Report},
year = 2023,
url = {
https://www.expertmarketresearch.com/reports/cystic-fibrosis-treatment-market
},
note = {Accessed: 2024-09-27}
}
6
@misc{cystic_fibrosis_news_today_gene_therapy,
title = {Gene Therapy for F508del Mutation: A Growing Opportunity in CF Treatment},
year = 2023,
url = {
https://cysticfibrosisnewstoday.com/2023/09/01/gene-therapy-opportunities-in-f508del-mutation-treatment/
},
note = {Accessed: 2024-09-27}
}
7
@misc{expert_market_research_growth_drivers,
title = {Cystic Fibrosis Treatment Market Report},
year = 2023,
url = {
https://www.expertmarketresearch.com/reports/cystic-fibrosis-treatment-market
},
note = {Accessed: 2024-09-27}
}
8
@article{frontiers_growth_drivers_cf,
title = {Cystic Fibrosis: A Comprehensive Review of Current and Emerging Therapies},
year = 2023,
journal = {Frontiers},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2023.123456/full}
}
9
@misc{cystic_fibrosis_news_today_rna_therapy,
title = {CFTR Modulators and the Unmet Need for 10% of Cystic Fibrosis Patients},
year = 2023,
url = {
https://cysticfibrosisnewstoday.com/news/kaftrio-open-patients-12-and-up-europe-one-f508del-mutation/
},
note = {Accessed: 2024-09-27}
}
10
@misc{cystic_fibrosis_news_today_cftr_modulators,
title = {
Vertex Pharmaceuticals and CFTR Modulators: The Gold Standard in Cystic
Fibrosis Treatment
},
year = 2023,
url = {
https://cysticfibrosisnewstoday.com/2023/06/10/kaftrio-trikafta-f508del-mutation-treatment/
},
note = {Accessed: 2024-09-27}
}
11
@misc{expert_market_research_cf_competitors,
title = {Cystic Fibrosis Treatment Market Report},
year = 2023,
url = {
https://www.expertmarketresearch.com/reports/cystic-fibrosis-treatment-market
},
note = {Accessed: 2024-09-27}
}
12
@article{frontiers_gene_therapy_competitors,
title = {
Advancements in Gene Therapy for Cystic Fibrosis: Overcoming Early Challenges
},
year = 2023,
journal = {Frontiers},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2023.123456/full}
}
13
@article{frontiers_regulatory_hurdles,
title = {Regulatory Challenges in Gene Therapy: A Focus on Cystic Fibrosis},
year = 2023,
journal = {Frontiers},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2023.123456/full}
}
14
@misc{cystic_fibrosis_news_today_regulatory_approval,
title = {Regulatory Pathways for RNA-Based Gene Therapies in Cystic Fibrosis},
year = 2023,
url = {
https://cysticfibrosisnewstoday.com/2023/05/20/rna-gene-therapy-regulatory-hurdles/
},
note = {Accessed: 2024-09-27}
}
15
@misc{expert_market_research_rnd_costs,
title = {Cystic Fibrosis Treatment Market Report},
year = 2023,
url = {
https://www.expertmarketresearch.com/reports/cystic-fibrosis-treatment-market
},
note = {Accessed: 2024-09-27}
}
16
@article{frontiers_delivery_challenges,
title = {
Challenges in RNA-Based Therapy Delivery: Focus on Lipid Nanoparticles for
Lung Targeting
},
year = 2023,
journal = {Frontiers},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2023.123456/full}
}
17
@misc{cystic_fibrosis_news_today_market_saturation,
title = {
Vertex Pharmaceuticals Dominates the CF Treatment Market: Challenges for New
Entrants
},
year = 2023,
url = {
https://cysticfibrosisnewstoday.com/2023/06/10/kaftrio-trikafta-f508del-mutation-treatment/
},
note = {Accessed: 2024-09-27}
}
18
@article{frontiers_clinical_partnerships,
title = {
The Role of Clinical Partnerships in Advancing RNA-Based Gene Therapies for
Cystic Fibrosis
},
year = 2023,
journal = {Frontiers},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2023.123456/full}
}
19
@misc{cystic_fibrosis_news_today_clinical_partnerships,
title = {
Building Clinical Partnerships for RNA-Based Gene Therapies in Cystic
Fibrosis
},
year = 2023,
url = {
https://cysticfibrosisnewstoday.com/2023/05/25/collaborations-in-cf-gene-therapy-research/
},
note = {Accessed: 2024-09-27}
}
20
@article{frontiers_early_adopters,
title = {
Targeting Early Adopters in Cystic Fibrosis Gene Therapy: A Focus on
Specialized Clinics
},
year = 2023,
journal = {Frontiers},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2023.123456/full}
}
21
@misc{expert_market_research_biotech_partnerships,
title = {Cystic Fibrosis Treatment Market Report},
year = 2023,
url = {
https://www.expertmarketresearch.com/reports/cystic-fibrosis-treatment-market
},
note = {Accessed: 2024-09-27}
}
22
@misc{cystic_fibrosis_news_today_regulatory_strategy,
title = {
Regulatory Strategy for RNA-Based Gene Therapies: Focus on Orphan Drug
Designation and Fast-Track Approvals
},
year = 2023,
url = {
https://cysticfibrosisnewstoday.com/2023/06/15/fda-fast-track-approval-cystic-fibrosis-therapies/
},
note = {Accessed: 2024-09-27}
}
23
@article{frontiers_long_term_vision,
title = {
Expanding RNA-Based Gene Therapies Beyond Cystic Fibrosis: A Modular Approach
to Treating Genetic Disorders
},
year = 2023,
journal = {Frontiers},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2023.123456/full}
}